Unrecognized glucose intolerance is common in pulmonary arterial hypertension
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND Animal and human data suggest insulin resistance is common in pulmonary arterial hypertension (PAH). Although routine assessment of insulin resistance is difficult, hemoglobin A1c (HbA1c) is a sensitive test to detect diabetes mellitus (DM) and those at high risk for diabetes. We aimed to define the prevalence of elevated HbA1c in PAH patients and to correlate HbA1c with functional assessment. METHODS HbA1c was measured in 41 PAH patients without a diagnosis of DM, along with demographic, functional, and hemodynamic data. Using published criteria, HbA1c ≤ 5.9% defined normal, 6.0–6.4% glucose intolerance, and ≥ 6.5% diabetes. RESULTS Twenty-three patients (56%) had HbA1c ≥ 6.0%, 6 patients (15%) had unrecognized DM (HbA1c ≥ 6.5%). Age and body mass index were similar in patients with HbA1c ≥ 6.0% versus HbA1c < 6.0%. There was a trend towards lower mean six-minute walk distance in patients with elevated HbA1c (331.0 ± 126.6 meters versus 413.6 ± 74.9 meters, p=0.07). Six-month event-free survival was not significantly different in patients with elevated HbA1c. CONCLUSIONS Unrecognized glucose intolerance as assessed by HbA1c is common in PAH. Further studies are needed to discern if glucose or insulin dysregulation mediates PAH pathogenesis or is secondary to advanced PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Snowling, N. J., & Hopkins, W. G. (2006) · Diabetes Care · doi:10.2337/dc06-1317 · Cited by 813
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Gregg, E. W., Ford, E. S., Geiss, L. S., Bainbridge, K. E., & Fradkin, J. E. (2010) · Diabetes Care · doi:10.2337/dc09-1524 · Cited by 689 · cited 1×
“HbA1c may not detect all glucose intolerant patients [12] and use of HbA1c may actually underestimate the burden of glucose intolerance and pre-diabetes.”
BackgroundLaaksonen, D. E., Lakka, H.-M., Salonen, J. T., Niskanen, L. K., Rauramaa, R., & Lakka, T. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1612 · Cited by 657 · cited 1×
“Given the association of low physical activity and insulin resistance [29, 39], non-pharmacologic management with exercise programs, dietary education, and weight loss may gain more importance in management of pulmonary vascular disease.”
BackgroundEffect of the volume and intensity of exercise training on insulin sensitivity
Houmard, J. A., Tanner, C. J., Slentz, C. A., Duscha, B. D., McCartney, J. S., & Kraus, W. E. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00707.2003 · Cited by 568
Cited by
The Metabolic Theory of Pulmonary Arterial Hypertension
Paulin, R., & Michelakis, E. D. (2014) · Circulation Research · doi:10.1161/circresaha.115.301130 · Cited by 314
Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure
Rosenkranz, S., Howard, L. S., Gomberg-Maitland, M., & Hoeper, M. M. (2020) · Circulation · doi:10.1161/circulationaha.116.022362 · Cited by 308
Lai, Y.-C., Tabima, D. M., Dube, J. J., Hughan, K. S., Vanderpool, R. R., Goncharov, D. A., St. Croix, C. M., Garcia-Ocaña, A., Goncharova, E. A., Tofovic, S. P., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.018935 · Cited by 270
The Metabolic Basis of Pulmonary Arterial Hypertension
Sutendra, G., & Michelakis, E. D. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.004 · Cited by 268
Paulin, R., Dromparis, P., Sutendra, G., Gurtu, V., Zervopoulos, S., Bowers, L., Haromy, A., Webster, L., Provencher, S., Bonnet, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.011 · Cited by 214
“In the absence of obesity or diabetes, many PAH patients have evidence of insulin resistance with a ‘‘metabolic syndrome-like’’ clinical picture, the presence of which is associated with worse clinical outcomes (Hansmann et al., 2007; Pugh et al., 2011; Zamanian et al., 2009).”
Background
Metadata
- Authors
- Pugh, M. E., Robbins, I. M., Rice, T. W., West, J., Newman, J. H., & Hemnes, A. R.
- Venue
- The Journal of Heart and Lung Transplantation
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 30
- Issue
- 8
- Pages
- 904-11
- ISSN
- 1053-2498 (ISSN-L)
- OpenAlex
- W1966590827
- Cited by
- 155
- References
- 17
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unrecognized glucose intolerance is common in pulmonary arterial hypertension. https://app.cochat.ai/papers/10.1016/j.healun.2011.02.016
- The paper
- Pugh, M. E., Robbins, I. M., Rice, T. W., West, J., Newman, J. H., & Hemnes, A. R. (2011). Unrecognized glucose intolerance is common in pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. https://doi.org/10.1016/j.healun.2011.02.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.